Earnings
NAVB
1.680
-3.45%
-0.060
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
2.67M
--
--
2.99M
--
--
0.00
--
169.80K
--
700.72K
--
6.53M
382.26K
--
--
--
--
620.24K
--
227.19K
1.23M
7.76M
--
1.16M
745.44K
--
--
--
--
--
2.78M
--
--
--
31.63K
4.72M
0.00
--
--
--
996.01K
1.73M
5.71M
219.14K
365.13M
-359.06M
--
--
731.30K
1.32M
2.05M
7.76M
FY 2019-12-31
1.05M
--
--
901.34K
--
--
0.00
--
--
--
967.29K
1.87M
2.92M
311.90K
--
--
--
--
385.41K
--
537.81K
1.24M
4.15M
--
1.11M
305.96K
--
--
--
--
--
2.39M
--
--
--
13.62K
3.82M
0.00
--
--
--
1.21M
1.94M
5.03M
211.13K
345.85M
-347.67M
--
--
731.30K
-1.61M
-880.99K
4.15M
FY 2018-12-31
3.48M
799.27K
--
21.15K
--
--
0.00
--
--
--
1.30M
--
5.60M
162.17K
--
--
--
--
428.49K
--
835.11K
1.43M
7.02M
--
424.72K
316.07K
--
--
--
--
--
2.52M
--
--
--
120.68K
3.38M
0.00
--
--
--
1.23M
1.90M
4.61M
200.39K
338.27M
-336.72M
--
--
668.32K
1.74M
2.41M
7.02M
FY 2017-12-31
2.80M
1.80M
--
8.14M
--
--
0.00
--
0.00
--
1.10M
--
13.83M
236.70K
4.81M
--
--
--
458.16K
--
1.44M
6.95M
20.78M
--
855.04K
0.00
--
--
--
--
--
1.86M
--
--
--
3.00M
8.07M
0.00
--
--
--
664.70K
1.33M
8.73M
162.21K
331.13M
-319.91M
--
--
668.70K
11.38M
12.05M
20.78M
FY 2016-12-31
1.54M
0.00
--
203.02K
--
--
0.00
--
96.21K
--
842.22K
8.15M
10.83M
1.18M
0.00
--
--
--
146.69K
--
308.14K
1.64M
12.46M
--
5.17M
0.00
--
--
--
--
--
7.87M
--
--
--
4.87M
69.86M
9.64M
--
--
--
624.92K
10.74M
80.13M
155.76K
326.56M
-394.86M
--
--
468.91K
-68.14M
-67.67M
12.46M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NAVB latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze NAVIDEA BIOPHARM recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.